R5 Final QA
TerminologyThis page is part of the FHIR Specification (v5.0.0-draft-final: Final QA Preview for R5 - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
. Page versions: R5 R4B
| Biomedical Research and Regulation Work Group | Maturity Level: 1 | Trial Use | Use Context: Country: World, Not yet ready for Production use |
Official URL: http://hl7.org/fhir/ValueSet/regulated-authorization-basis
|
Version: 5.0.0-draft-final | |||
| draft as of 2020-12-28 | Computable Name: RegulatedAuthorizationBasis | |||
| Flags: Experimental, Immutable | OID: 2.16.840.1.113883.4.642.3.2997 | |||
This value set is used in the following places:
A legal or regulatory framework against which an authorization is granted, or other reasons for it.
http://hl7.org/fhir/regulated-authorization-basis
This expansion generated 01 Mar 2023
This value set contains 10 concepts
Expansion based on Regulated Authorization Basis v5.0.0-draft-final (CodeSystem)
| Code | System | Display |
| Full | http://hl7.org/fhir/regulated-authorization-basis | Full application |
| NewSubstance | http://hl7.org/fhir/regulated-authorization-basis | New active substance |
| KnownSubstance | http://hl7.org/fhir/regulated-authorization-basis | Known active substance |
| SimilarBiological | http://hl7.org/fhir/regulated-authorization-basis | Similar biological application |
| Well-establishedUse | http://hl7.org/fhir/regulated-authorization-basis | Well-established use application |
| TraditionalUse | http://hl7.org/fhir/regulated-authorization-basis | Traditional use registration for herbal medicinal product application |
| Bibliographical | http://hl7.org/fhir/regulated-authorization-basis | Bibliographical application (stand-alone) |
| KnownHumanBlood | http://hl7.org/fhir/regulated-authorization-basis | Known human blood/plasma derived ancillary medicinal substance |
| TemporaryUse | http://hl7.org/fhir/regulated-authorization-basis | Authorizations for temporary use |
| ParallelTrade | http://hl7.org/fhir/regulated-authorization-basis | Parallel traded products |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
FHIR ®© HL7.org 2011+. FHIR R5 hl7.fhir.core#5.0.0-draft-final generated on Wed, Mar 1, 2023 23:05+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change